PoshanSense
Diet questions · 5 min read

Low-fat or low-carb: which works better for weight loss?

A year-long US trial found no clear average winner when both approaches emphasized food quality. The useful question is which routine you can maintain.

Two varied meal plates with chicken, fish, vegetables, beans, grains and avocado on a terracotta table.
Original conceptual illustration, not a prescribed diet or trial menu.

Complementary human studies · Published 2018 & 2022

Two people can argue fiercely about low-fat and low-carb while making surprisingly similar useful changes: cooking more often, replacing sugary drinks and paying attention to portions. The diet label can hide that shared work.

The practical answer is not that fat and carbohydrate are interchangeable in every medical situation. It is that an average weight-loss advantage should not be assumed from the name. A plan still has to fit your food, finances, family and health.

What did a large direct comparison find?

In DIETFITS, 609 adults without diabetes were randomized and 481 supplied 12-month data. Average losses were about 5.3 kg on healthy low-fat and 6.0 kg on healthy low-carb, without a statistically significant difference. The result does not mean each participant lost that amount.

Both groups received substantial education and emphasized vegetables while reducing added sugars and refined grains. Neither was assigned a fixed calorie target. The predefined genotype pattern and insulin-secretion measurement did not reliably identify which approach would produce greater weight loss.

Low-carb did not mean zero-carb forever

Diet names often sound more extreme than the routine people eventually follow. In this study, participants began with a strong reduction in their assigned nutrient, then gradually increased it to a level they felt they could maintain. At a year, the low-carb group was not uniformly eating a strict ketogenic diet.

That distinction matters when a video borrows the trial to advertise a much more restrictive plan. Evidence for one supported approach is not automatic evidence for every commercial diet using the same words. Ask what people actually ate, not only what their group was called.

The paper also reports different blood-lipid patterns between groups. Those secondary outcomes remind us that a weight comparison cannot decide every health question. If cholesterol or diabetes treatment is part of your situation, discuss those outcomes with a qualified professional rather than treating the bathroom scale as the entire scorecard.

Original explanatory infographic

Choose a routine, not a winning slogan

01

Average weight loss

About 5.3 kg on healthy low-fat and 6.0 kg on healthy low-carb; no significant difference.

02

Shared priorities

Vegetables, fewer refined grains and added sugars, and sustained support.

03

Individual variation

Group averages do not forecast your result.

04

Health context

Weight, blood lipids, medication safety and nutritional adequacy are different questions.

DIETFITS averages at 12 months; these are not promised personal losses or results from unsupervised commercial plans.

Can you use the answer with local foods?

Yes—as a way to ask better questions, not as a recipe transplanted from California. Consider the meals you already eat. In one household the main decisions involve bread and cheese; in another, rice, dal and cooking oil. A lower-fat or lower-carb version needs realistic replacements, not simply a longer forbidden-food list.

Make the change concrete. If you reduce a usual food, what takes its place? Is that replacement satisfying, affordable and practical? Does the plan still allow meals with other people? These are useful planning questions whether you live in Delhi, Manchester or Chicago.

Food quality is not a decorative extra after choosing a macronutrient target. A lower-fat snack can still be mostly refined flour and sugar. A lower-carb meal can still be built around foods you would not want at every meal. Look at the ingredients and the pattern, not just the nutrient being reduced.

Does everyone respond the same way?

No. Similar group averages leave room for considerable individual variation. They also leave unanswered questions about why one person finds a routine easier than another. The trial failed to validate two particular predictors; it did not prove that biology, preferences or circumstances are irrelevant.

A DNA-based diet advertisement should therefore explain exactly which test it uses and what outcomes validate it. “Personalized” sounds reassuring, but the word alone is not scientific evidence. DIETFITS is a reminder that plausible predictors need prospective testing.

Keep your own evaluation broader than a few days of scale movement. Can you shop and cook this way? Are meals satisfying? Are you cutting out foods you enjoy without a useful replacement? If the routine creates constant friction, that is information worth bringing to a dietitian.

How does this fit with keto and other studies?

The 2022 Keto-Med experiment asked a different question in people with prediabetes or type 2 diabetes. Its main blood-sugar comparison did not clearly favour either pattern, and it found lipid trade-offs. It was not a second year-long weight-loss test.

Combining findings should sharpen the answer rather than pretend these were identical experiments. DIETFITS helps answer an average weight-loss question. Keto-Med adds a reminder that a diet chosen for blood sugar may have other consequences. Neither supplies a universal unsupervised prescription.

Before a substantial change, seek individual advice if you take glucose-lowering medicines or have a condition affecting your nutritional needs. For everyone else, begin with the meals you can realistically improve and maintain. A useful eating routine should be understandable without requiring loyalty to a diet slogan.

Evidence context: DIETFITS reported NIH and Nutrition Science Initiative support, no author conflicts and no funder role. Its online paper includes corrections to lipid units and funding wording; those corrections were checked.

Sources & further reading

  1. United States · DIETFITS (2018)
  2. 2022 Keto-Med trial: a different clinical comparison
  3. 2018 DIETFITS funding correction
  4. 2018 DIETFITS lipid-unit correction

Study years differ from this article’s publication date. We reviewed full primary papers and relevant supporting material; access limitations are kept out of efficacy claims. Original illustrations and diagrams; no publisher figures reproduced. Educational writing, not clinical review.

Published 11 October 2026 · Sources checked 11 October 2026. Suggest a correction.